Correction: Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003375/
https://www.ncbi.nlm.nih.gov/pubmed/31958286
http://dx.doi.org/10.1136/esmoopen-2019-000599corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003375/
https://www.ncbi.nlm.nih.gov/pubmed/31958286
http://dx.doi.org/10.1136/esmoopen-2019-000599corr1

Ejemplares similares